ASTRAZENECA Stock Analysis

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>AP</div>
Is it time to take up ASTRAZENECA PHARMA? ASTRAZENECA PHARMA Stock analysis can help investors discover the best opportunities and time the market in virtually any economy. Find the stocks trading at a discount of their intrinsic value will give you an edge in creating a market-bitting portfolio. The current indifference towards the small price fluctuations of ASTRAZENECA PHARMA could raise concerns from investors as the firm closed today at a share price of 0.0 on very low momentum in volume. The company executives did not add any value to ASTRAZENECA PHARMA investors in June. However, most investors can still diversify their portfolios with ASTRAZENECA PHARMA to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer term investment horizons. Check out Trending Equities.

Search Stock Analysis

The ASTRAZENECA PHARMA Stock analysis interface makes it easy to digest most current publicly released information about ASTRAZENECA PHARMA as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. ASTRAZENECA stock analysis module also helps to analyze ASTRAZENECA PHARMA price relationship with some important fundamental indicators such as market cap and management efficiency.

ASTRAZENECA Stock Analysis Notes

The company recorded earning per share (EPS) of 21.78. ASTRAZENECA PHARMA last dividend was issued on the 19th of August 1970. AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca PLC. ASTRAZENECA PHARMA operates under Drug Manufacturers - Major classification in India and is traded on Bombay Stock Exchange. It employs 1452 people. For more info on ASTRAZEN PHA please contact the company at 91 80 6774 8000 or go to


ASTRAZENECA PHARMA is not yet fully synchronised with the market data
ASTRAZENECA PHARMA has some characteristics of a very speculative penny stock

Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 47.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ASTRAZENECA PHARMA's market, we take the total number of its shares issued and multiply it by ASTRAZENECA PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.


The company has Profit Margin (PM) of 7.48 %, which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 7.77 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.08.

Management Efficiency

The entity has return on total asset (ROA) of 6.92 % which means that it generated profit of $6.92 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 19.88 %, meaning that it generated $19.88 on every $100 dollars invested by stockholders. ASTRAZENECA PHARMA management efficiency ratios could be used to measure of how well astrazeneca pharma is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.

ASTRAZENECA PHARMA Technical and Predictive Indicators

Did you try this?

Run Balance Of Power Now


Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module
Check out Trending Equities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page